Insulet Valuation
| GOV Stock | EUR 213.00 3.10 1.48% |
At this time, the firm appears to be overvalued. Insulet retains a regular Real Value of €178.92 per share. The prevalent price of the firm is €213.0. Our model calculates the value of Insulet from evaluating the firm fundamentals such as Current Valuation of 15.03 B, return on asset of 0.0943, and Return On Equity of 0.18 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 11.4802 | Enterprise Value 15 B | Enterprise Value Ebitda 36.1606 | Price Sales 5.4147 | Forward PE 39.6825 |
Overvalued
Today
Please note that Insulet's price fluctuation is very steady at this time. Calculation of the real value of Insulet is based on 3 months time horizon. Increasing Insulet's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Insulet stock is determined by what a typical buyer is willing to pay for full or partial control of Insulet. Since Insulet is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Insulet Stock. However, Insulet's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 213.0 | Real 178.92 | Hype 212.46 | Naive 219.3 |
The real value of Insulet Stock, also known as its intrinsic value, is the underlying worth of Insulet Company, which is reflected in its stock price. It is based on Insulet's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Insulet's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Insulet helps investors to forecast how Insulet stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Insulet more accurately as focusing exclusively on Insulet's fundamentals will not take into account other important factors: Insulet Cash |
|
Insulet Total Value Analysis
Insulet is currently estimated to have takeover price of 15.03 B with market capitalization of 14.66 B, debt of 18.4 M, and cash on hands of 316.37 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Insulet fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.03 B | 14.66 B | 18.4 M | 316.37 M |
Insulet Investor Information
About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.83. Insulet had not issued any dividends in recent years. Based on the key indicators related to Insulet's liquidity, profitability, solvency, and operating efficiency, Insulet is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.Insulet Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Insulet has an asset utilization ratio of 64.93 percent. This implies that the Company is making €0.65 for each dollar of assets. An increasing asset utilization means that Insulet is more efficient with each dollar of assets it utilizes for everyday operations.Insulet Profitability Analysis
Based on Insulet's profitability indicators, Insulet may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Insulet's ability to earn profits and add value for shareholders.Net Income | First Reported 2016-12-31 | Previous Quarter 22.5 M | Current Value 87.6 M | Quarterly Volatility 43.7 M |
For Insulet profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Insulet to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Insulet utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Insulet's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Insulet over time as well as its relative position and ranking within its peers.
Insulet Earnings per Share Projection vs Actual
By analyzing Insulet's earnings estimates, investors can diagnose different trends across Insulet's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Insulet is based on EPS before non-recurring items and includes expenses related to employee stock options.Insulet Ownership Allocation
Insulet has a total of 70.4 Million outstanding shares. The majority of Insulet outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Insulet to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Insulet. Please pay attention to any change in the institutional holdings of Insulet as this could imply that something significant has changed or is about to change at the company. Also note that almost six thousand three hundred thirty-six invesors are currently shorting Insulet expressing very little confidence in its future performance.Insulet Profitability Analysis
The company reported the revenue of 2.07 B. Net Income was 247.1 M with profit before overhead, payroll, taxes, and interest of 1.94 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Insulet's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Insulet and how it compares across the competition.
About Insulet Valuation
The stock valuation mechanism determines Insulet's current worth on a weekly basis. Our valuation model uses a comparative analysis of Insulet. We calculate exposure to Insulet's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Insulet's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.7 B | 1.7 B |
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |